Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome

Fecha de emisión

2019

Autor(es)

Di Domenico F.

Tramutola A.

Barone E.

Lanzillotta C.

Defever O.

Arena A.

Zuliani I.

Foppoli C.

Iavarone F.

Vincenzoni F.

Castagnola M.

Butterfield D.A.

Perluigi M.

DOI

10.1016/j.redox.2019.101162

Temas

Archivo(s)

Name

item_2s2.085062690014.pdf

Size

4.9 KB

Format

Checksum